One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Dyne Therapeutics logo
Dyne Therapeutics DYN
$ 15.89 -0.81%
report update icon

Quarterly report 2026-Q3
added 11-05-2026

Dyne Therapeutics Financial Statements 2025-2011 | DYN

Annual Financial Statements Dyne Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.64 B 1.34 B 1.58 B 816 M 436 M 134 M - - - - - - - 2.02 B -

Shares

165 M 102 M 61.5 M 55.6 M 50.9 M 6.92 M - - - - - - - 100 M -

Historical Prices

16 13.1 25.7 14.7 8.57 18.5 - - - - - - - - -

Net Income

-446 -317 -236 -168 -149 M -59.4 M -14.9 M -4.81 M 76 M -1.24 B 50 M -67 M -356 M 87 M -1.64 B

Revenue

- - - - - - - - 506 M 1.37 B 842 M 1.47 B 3 M 3 M 1.58 B

Cost of Revenue

86.5 M 63.3 M 48.9 M 35.3 M - - - - - - - - - - -

Gross Profit

- - - - - - - - 1.91 B 2.04 B 1.84 B 321 M 321 M 3 M 622 M

Operating Income

-468 M -344 M -242 M -171 M -150 M -58.6 M -13.8 M - - - - - - - -

Interest Expense

22 M 26.5 M 6.22 M 2.86 M 734 K -790 K -1.03 M - - - - - - - -

EBITDA

-466 M -342 M -240 M -169 M -149 M -57.9 M -13.6 M -4.77 M 455 M 126 M 678 M -26 M 149 M 740 M 110 M

Operating Expenses

468 M 344 M 242 M 171 M 150 M 58.6 M 13.8 M 4.8 M 189 M 161 M 128 M -308 M 97 M -81 M 135 M

General and Administrative Expenses

69.9 M 62.5 M 31.4 M 28.2 M 28.7 M 13.4 M 2.79 M 517 K 189 M 161 M 128 M -97 M 97 M -22 M 135 M

All numbers in USD currency

Quarterly Income Statement Dyne Therapeutics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

187 M 166 M 165 M 165 M 143 M 114 M 114 M 102 M 102 M 100 M 87.1 M 61.5 M 61.3 M 61 M 58.3 M 55.6 M 51.9 M - 51.6 M 218 K 51.3 M 51.2 M 49.5 M 10.3 M 6.92 M 2.71 M 8.76 M 2.59 M 2.49 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-194 M -179 M -121 M -112 M -108 M -111 M -115 M -89.5 M -97.1 M -65.1 M -65.6 M -66.6 M -60.2 M -64.9 M -44.2 M -38.8 M -41.4 M -52.3 M -35.6 M -51.8 M -42.6 M -30 M -25 M -28.6 M -13.9 M -8.98 M -7.89 M - -14.9 M -1.5 M -2.09 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

32.3 M 28.8 M 28.6 M 23.7 M 22.5 M 19.5 M 20.7 M 18.3 M 15.6 M 13.6 M 15.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-197 M -182 M -125 M -116 M -114 M -116 M -122 M -97.1 M -106 M -72 M -69.2 M -67.7 M -62.3 M -66.7 M -45.5 M -40.1 M -42.3 M -52.8 M -35.8 M -52 M -42.8 M -30.2 M -25.1 M -28.6 M -13.5 M -8.68 M -7.85 M - -3.63 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

3.52 M 3.1 M 4.42 M 4.17 M 5.85 M 4.93 M 7.01 M 7.57 M 8.53 M 6.86 M 3.51 M 1.05 M 2.06 M 1.83 M 1.28 M 1.32 M 894 K 451 K 200 K 174 K 184 K 210 K 166 K -49 K -400 K -307 K -33 K - -2.24 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-196 M -181 M -125 M -116 M -113 M -115 M -122 M -96.7 M -105 M -71.6 M -68.8 M -67.3 M -61.9 M -66.3 M -45.1 M -39.7 M -41.9 M -52.3 M -35.4 M -51.6 M -42.5 M -30 M -24.9 M -28.4 M -13.3 M -8.48 M -7.7 M - -3.53 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

197 M 182 M 125 M 116 M 114 M 116 M 122 M 97.1 M 106 M 72 M 69.2 M 67.7 M 62.3 M 66.7 M 45.5 M 40.1 M 42.3 M 52.8 M 35.8 M 52 M 42.8 M 30.2 M 25.1 M 28.6 M 13.5 M 8.68 M 7.85 M - 3.63 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

35.3 M 29.5 M 24.4 M 20.7 M 16.7 M 16.6 M 15.9 M 15.3 M 12.9 M 9.7 M 24.6 M 8.84 M 7.02 M 7.61 M 7.93 M 6.96 M 7.61 M 6.09 M 7.55 M 9.66 M 6.26 M 6.29 M 6.51 M 6.5 M 3.84 M 1.34 M 1.76 M - 647 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Dyne Therapeutics DYN
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Dyne Therapeutics plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Utilities industry

Issuer Price % 24h Market Cap Country
Sempra Energy Sempra Energy
SRE
$ 77.51 -0.01 % $ 50.6 B usaUSA
Kenon Holdings Ltd. Kenon Holdings Ltd.
KEN
$ 57.8 -1.87 % $ 3.01 B singaporeSingapore
TransAlta Corporation TransAlta Corporation
TAC
$ 12.79 -0.2 % $ 3.8 B canadaCanada
MGE Energy MGE Energy
MGEE
$ 80.25 2.58 % $ 2.93 B usaUSA
NextEra Energy Partners, LP NextEra Energy Partners, LP
NEP
- 0.96 % $ 895 M usaUSA
Otter Tail Corporation Otter Tail Corporation
OTTR
$ 77.56 3.81 % $ 3.25 B usaUSA
Ormat Technologies Ormat Technologies
ORA
$ 91.45 3.16 % $ 5.55 B usaUSA
Huaneng Power International Huaneng Power International
HNP
- -3.99 % $ 11.7 B chinaChina
Just Energy Group Inc. Just Energy Group Inc.
JE
- -19.51 % $ 7.74 M canadaCanada
Vistra Corp. Vistra Corp.
VST
$ 125.41 -1.37 % $ 42.5 B usaUSA
Companhia Paranaense de Energia - COPEL Companhia Paranaense de Energia - COPEL
ELP
- - $ 5.14 B brasilBrasil
Transportadora de Gas del Sur S.A. Transportadora de Gas del Sur S.A.
TGS
$ 20.27 -1.27 % $ 15.3 B argentinaArgentina
Atlantic Power Corporation Atlantic Power Corporation
AT
- - $ 273 M usaUSA
Cosan Limited Cosan Limited
CZZ
- 2.01 % $ 4.53 B brasilBrasil
Unitil Corporation Unitil Corporation
UTL
$ 55.71 0.69 % $ 935 M usaUSA
China Recycling Energy Corporation China Recycling Energy Corporation
CREG
- - $ 11.7 M chinaChina
Dominion Energy Dominion Energy
DCUE
- -0.76 % $ 67.9 B usaUSA
Entergy Corporation Entergy Corporation
ETR
$ 108.42 0.79 % $ 47.9 B usaUSA
FirstEnergy Corp. FirstEnergy Corp.
FE
$ 47.7 1.36 % $ 27.5 B usaUSA
Orbital Energy Group Orbital Energy Group
OEG
- 2.29 % $ 53.4 M usaUSA
Enel Américas S.A. Enel Américas S.A.
ENIA
- -4.28 % $ 10.3 B chileChile
Atlantica Sustainable Infrastructure plc Atlantica Sustainable Infrastructure plc
AY
- - $ 2.45 B britainBritain
Brookfield Infrastructure Partners L.P. Brookfield Infrastructure Partners L.P.
BIP
$ 42.01 4.48 % $ 19.2 B bermudaBermuda
ALLETE ALLETE
ALE
- - $ 3.92 B usaUSA
South Jersey Industries South Jersey Industries
SJI
- - $ 4.42 B usaUSA
The AES Corporation The AES Corporation
AES
$ 15.02 0.3 % $ 10.7 B usaUSA
Black Hills Corporation Black Hills Corporation
BKH
$ 86.7 -0.91 % $ 6.33 B usaUSA
Brookfield Renewable Partners L.P. Brookfield Renewable Partners L.P.
BEP
$ 30.5 1.3 % $ 13 B bermudaBermuda
Clearway Energy Clearway Energy
CWEN
$ 32.0 2.2 % $ 6.52 B usaUSA
Dominion Energy Dominion Energy
D
$ 67.16 -0.18 % $ 57.4 B usaUSA
Algonquin Power & Utilities Corp. Algonquin Power & Utilities Corp.
AQN
$ 5.59 -0.27 % $ 4.29 B canadaCanada
Exelon Corporation Exelon Corporation
EXC
$ 46.01 0.33 % $ 46.5 B usaUSA
Companhia Energética de Minas Gerais Companhia Energética de Minas Gerais
CIG
$ 1.83 -1.88 % $ 6.42 B brasilBrasil
National Grid plc National Grid plc
NGG
$ 82.17 -0.47 % $ 387 B britainBritain
NRG Energy NRG Energy
NRG
$ 93.61 1.94 % $ 18.3 B usaUSA
Enel Chile S.A. Enel Chile S.A.
ENIC
$ 4.06 -2.17 % $ 281 M -
Ellomay Capital Ltd. Ellomay Capital Ltd.
ELLO
$ 17.91 0.9 % $ 230 M israelIsrael
Public Service Enterprise Group Incorporated Public Service Enterprise Group Incorporated
PEG
$ 74.51 -0.15 % $ 37.2 B usaUSA
Avista Corporation Avista Corporation
AVA
$ 39.68 0.25 % $ 3.21 B usaUSA
Azure Power Global Limited Azure Power Global Limited
AZRE
- - $ 108 M indiaIndia
NorthWestern Corporation NorthWestern Corporation
NWE
$ 84.91 -0.81 % $ 4.95 B usaUSA